CVS Health Vendor and manufacturer receivables increased by 16.6% to $17.78B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.8%, from $15.62B to $17.78B. Over 3 years (FY 2021 to FY 2024), Vendor and manufacturer receivables shows an upward trend with a 9.5% CAGR.
other_vendor_and_manufacturer_receivables| Q4 '21 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.57B | $13.53B | $12.40B | $13.36B | $14.91B | $16.65B | $15.71B | $12.68B | $13.53B | $15.62B | $13.89B | $14.21B | $15.25B | $17.78B |
| QoQ Change | — | +28.0% | -8.4% | +7.8% | +11.6% | +11.6% | -5.6% | -19.3% | +6.7% | +15.5% | -11.1% | +2.3% | +7.3% | +16.6% |
| YoY Change | — | — | +17.2% | — | — | +23.0% | +26.8% | -5.1% | -9.3% | -6.2% | -11.6% | +12.0% | +12.7% | +13.8% |